ReviewRSC medicinal chemistry2024

Beyond inhibition against the PD-1/PD-L1 pathway: development of PD-L1 inhibitors targeting internalization and degradation of PD-L1.

Jiazheng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.